# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-24-000031
Filing Date
2024-11-04
Accepted
2024-11-04 08:47:12
Documents
52
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vrna-20240930.htm iXBRL | 10-Q | 1243579
2 | EX-31.1 | exhibit311q324.htm | EX-31.1 | 8960
3 | EX-31.2 | exhibit312q324.htm | EX-31.2 | 9002
4 | EX-32.1 | exhibit321q324.htm | EX-32.1 | 5243
5 | EX-32.2 | exhibit322q324.htm | EX-32.2 | 5326
11 | GRAPHIC | vrna-20240930_g1.jpg | GRAPHIC | 157409
| Complete submission text file | 0001657312-24-000031.txt |  | 4899015

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vrna-20240930.xsd | EX-101.SCH | 29805
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vrna-20240930_cal.xml | EX-101.CAL | 50202
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vrna-20240930_def.xml | EX-101.DEF | 94044
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vrna-20240930_lab.xml | EX-101.LAB | 413121
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vrna-20240930_pre.xml | EX-101.PRE | 262484
55 | EXTRACTED XBRL INSTANCE DOCUMENT | vrna-20240930_htm.xml | XML | 406193

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 241420971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)